2023 Apr;160:114376
doi: 10.4049/jimmunol.175.2.1310 Summary Keywords thyroid, COVID-19 vaccine, hyperthyroidism, autoimmune, SARS-CoV-2, Graves disease, inflammatory syndrome, ACE2 Citation Murugan AK and Alzahrani AS (2025) COVID-19 vaccine-induced autoimmune hyperthyroidism: Graves disease
In addition to improved patient-reported symptom-based outcomes, ARA 290 administration was also associated with a significant increase in corneal small nerve fiber density, changes in cutaneous temperature sensitivity, and an increased exercise capacity as assessed by the 6-minute walk test
There is no single test or biomarker that can definitively confirm IgG4-RD, but information from all these tests helps build a fuller picture that points to the diagnosis Q: If I have unexplained headaches and swollen glands or eye pain, does it mean I need to be evaluated for IgG4-RD